Literature DB >> 10924968

Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma?

E P Jansen1, R B Keus, F J Hilgers, R L Haas, I B Tan, H Bartelink.   

Abstract

PURPOSE: To determine the contribution of debulking surgery on local control and survival in paranasal sinus tumors. As most patients present with locally advanced disease, the possibility of radical surgery is limited. Consequently, radiotherapy is often needed as monotherapy or as an adjunct to surgery. METHODS AND MATERIALS: Between 1977 and 1996, 73 patients (50 male: 23 female) with a paranasal sinus carcinoma were treated. The histology distribution was as follows: squamous cell carcinoma, 55%; adenocarcinoma, 19%; adenoid cystic carcinoma, 11%; and undifferentiated carcinoma, 15%. The clinical T classification was (UICC/TNM 1997): T2 14%, T3 27%, and T4 59%. Pathological neck nodes were found in 11% of patients. Treatment consisted of surgery only in 3, chemotherapy only in 1, radiotherapy only in 18, both surgery and radiotherapy in 50 patients. One patient did not receive any treatment at all. Three patients had concurrent chemotherapy. Median follow-up was 66 months (range, 1-213 months).
RESULTS: Five-year local control (LC) was 65% with combination of radiotherapy and debulking surgery in comparison with 47% with radiotherapy alone, but this difference was not statistically significant (p = 0.58). However, combination treatment gave significantly better 5-year overall survival (OS) (60% vs. 9%; p = 0.001) and 5-year disease-free survival (DFS) (53% vs. 6%; p < 0. 0001). Cox-regression analysis showed that pathologic N status (p = 0.04), palliative intention of treatment (p = 0.018), clinical orbital invasion (p = 0.003), and orbital wall invasion (p = 0.003) were parameters significantly associated with poor local control. Total radiation dose of greater than 65 Gy (p = 0.05) and treatment consisting of radiotherapy alone (p = 0.002) were associated with worse overall survival; for disease-free survival clinical orbital invasion (p = 0.0005), age of greater than 65 years (p = 0.013) and pathologic T4 classification (p = 0.002) were significant factors for an unfavorable outcome. In 19 of 73 patients, 26 serious (mainly ophthalmological) complications were reported; in the majority of these, the visual tract was (partly) included in the treatment fields because of tumor extension. To analyze on which basis patients were selected for the combination therapy, a logistic regression was performed, concluding that clinical T4 classification (p = 0.05), radiological evidence of skull base invasion (p = 0.005), age of greater than 65 years (p = 0.026), radiological evidence of nasopharynx invasion (p = 0.02), clinical suspicion of palate invasion (p = 0.02), and radiological evidence of skin invasion (p = 0.009) were associated with choosing radiotherapy alone.
CONCLUSION: Debulking surgery of paranasal sinus malignancies followed by high-dose radiotherapy to the involved sites was associated with better survival and (although not statistically significant) local control. Patient selection, based on clinical and radiological impression of tumor extension, was the main factor explaining these favorable results. We favor this combination regimen because the surgery gives quick relief of complaints and, at the same time, offers an excellent histologically proven staging method, enabling radiotherapy to be adjusted to the involved sites, thereby decreasing the risk of complications. This can all be achieved with a very low orbital exenteration rate.

Entities:  

Mesh:

Year:  2000        PMID: 10924968     DOI: 10.1016/s0360-3016(00)00594-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

1.  [Intensity modulated radiotherapy (IMRT) of head and neck tumors. Increased biological effectiveness in high-risk situations by "integrated boost" therapy].

Authors:  D Milanovic; F Lohr; K Götte; B Dobler; B Hermann; K Hörmann; F Wenz
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

2.  Proton beam therapy for locally advanced and unresectable (T4bN0M0) squamous cell carcinoma of the ethmoid sinus: A report of seven cases and a literature review.

Authors:  Takashi Saito; Hitoshi Ishikawa; Kayoko Ohnishi; Teruhito Aihara; Masashi Mizumoto; Nobuyoshi Fukumitsu; Kaori Sugawara; Toshiyuki Okumura; Hideyuki Sakurai
Journal:  Oncol Lett       Date:  2015-05-15       Impact factor: 2.967

3.  Craniofacial Resection for Sinonasal Malignant Tumors: Statistical Analysis of Surgical Outcome over 17 Years at a Single Institution.

Authors:  Seiichiro Mine; Naokatsu Saeki; Kentaro Horiguchi; Toyoyuki Hanazawa; Yoshitaka Okamoto
Journal:  Skull Base       Date:  2011-07

4.  Outcomes of nonsurgical management of locally advanced carcinomas of the sinonasal cavity.

Authors:  Shamit Chopra; Dev P Kamdar; David S Cohen; Lance K Heilbrun; Daryn Smith; Harold Kim; Ho-Sheng Lin; John R Jacobs; George Yoo
Journal:  Laryngoscope       Date:  2016-11-15       Impact factor: 3.325

5.  A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.

Authors:  Tyler P Robin; Bernard L Jones; Oren M Gordon; Andy Phan; Diana Abbott; Jessica D McDermott; Julie A Goddard; David Raben; Ryan M Lanning; Sana D Karam
Journal:  Cancer       Date:  2017-04-03       Impact factor: 6.860

6.  Comparative outcome of surgical and nonsurgical therapy for T4bN0M0 sinonasal squamous cell carcinomas.

Authors:  Ruichen Li; Shu Tian; Lan Lin; Quan Liu; Shengzi Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-26       Impact factor: 2.503

7.  Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.

Authors:  Sadamoto Zenda; Mitsuhiko Kawashima; Satoko Arahira; Ryosuke Kohno; Teiji Nishio; Makoto Tahara; Ryuichi Hayashi; Tetsuo Akimoto
Journal:  Int J Clin Oncol       Date:  2014-08-20       Impact factor: 3.402

8.  Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma.

Authors:  Koji Kawaguchi; Kengo Sato; Akihisa Horie; Susumu Iketani; Hiroyuki Yamada; Yasunori Nakatani; Junichi Sato; Yoshiki Hamada
Journal:  Radiat Oncol       Date:  2010-06-09       Impact factor: 3.481

9.  Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases.

Authors:  Lester D R Thompson; Carla Penner; Ngoc J Ho; Robert D Foss; Markku Miettinen; Jacqueline A Wieneke; Christopher A Moskaluk; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2013-09-15

Review 10.  Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis.

Authors:  Bijan Khademi; Azadeh Moradi; Sara Hoseini; Mohammad Mohammadianpanah
Journal:  Oral Maxillofac Surg       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.